News - Page 236 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Havn Life Sciences Partners With Veterans Mental Health Non-Profit, Westwood Institute

Havn Life Sciences Partners With Veterans Mental Health Non-Profit, Westwood Institute

Post published:December 3, 2020
Post category:Press Release

Read more about the article Red Light Holland Names Internationally Renowned & Award-Winning Designer Karim Rashid as Head of Design

Red Light Holland Names Internationally Renowned & Award-Winning Designer Karim Rashid as Head of Design

Post published:December 3, 2020
Post category:Press Release

Read more about the article Nova Mentis Appoints Dr. Marvin S. Hausman as Chairman of Scientific Advisory Board

Nova Mentis Appoints Dr. Marvin S. Hausman as Chairman of Scientific Advisory Board

Post published:December 3, 2020
Post category:Press Release

Read more about the article Field Trip Health Ltd. Provides Operational and Investor Update, Announces Expanded Hours at its Field Trip Health Center in Toronto plus Rollout of Portal, Field Trip’s Proprietary Digital Mental Health Platform

Field Trip Health Ltd. Provides Operational and Investor Update, Announces Expanded Hours at its Field Trip Health Center in Toronto plus Rollout of Portal, Field Trip’s Proprietary Digital Mental Health Platform

Post published:December 3, 2020
Post category:Press Release

Read more about the article Lobe Sciences Commences Engineering of Nasal Mist Device

Lobe Sciences Commences Engineering of Nasal Mist Device

Post published:December 3, 2020
Post category:Press Release

Read more about the article Epidemiologist Dr. Joel Moody Joins Revive Therapeutics as Medical and Clinical Advisor

Epidemiologist Dr. Joel Moody Joins Revive Therapeutics as Medical and Clinical Advisor

Post published:December 2, 2020
Post category:Press Release

Read more about the article Silo Pharma Announces Plans for a Phase 2B Investigator Lead Study Using Psychedelics Psilocybin and Lysergic Acid Diethylamide (“LSD”) to Treat Parkinson’s Disease

Silo Pharma Announces Plans for a Phase 2B Investigator Lead Study Using Psychedelics Psilocybin and Lysergic Acid Diethylamide (“LSD”) to Treat Parkinson’s Disease

Post published:December 2, 2020
Post category:Press Release

Read more about the article Pure Extracts Collaborates with Dr. Alexander MacGregor on Cannabis and Mushroom Formulations

Pure Extracts Collaborates with Dr. Alexander MacGregor on Cannabis and Mushroom Formulations

Post published:December 2, 2020
Post category:Press Release

Read more about the article Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial

Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial

Post published:December 2, 2020
Post category:Press Release

Read more about the article Havn Life Attracts International Drug Science and Policy Expert, Joins UK Policy Reform Group

Havn Life Attracts International Drug Science and Policy Expert, Joins UK Policy Reform Group

Post published:December 2, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.